News Conference News ACC 2017 MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns L.A. McKeown March 27, 2017
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
News Conference News ACC 2017 Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports Michael O'Riordan March 24, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients L.A. McKeown March 21, 2017
Presentation ACC 2017 Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017
News Conference News ACC 2017 Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI Caitlin E. Cox March 20, 2017
News Conference News ACC 2017 Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit Todd Neale March 19, 2017
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
Presentation ACC 2017 First Results from the SURTAVI Clinical Trial Presenter: Michael J. Reardon March 17, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation ACC 2016 SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis Presenter: Vinod Thourani April 01, 2016